Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name CMB305
Trade Name
Synonyms ID-CMB305|CMB 305
Drug Descriptions

CMB305 is a combination of LV305, a dendritic cell-targeted lentiviral vector encoding NY-ESO-1, and G305, an NY-ESO-1 cancer vaccine, which may synergize to promote anti-tumor immunity (PMID: 29280411).

DrugClasses
CAS Registry Number NA
NCIT ID C122922

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Aldesleukin + CMB305 + Cyclophosphamide + ID-LV305 Aldesleukin CMB305 Cyclophosphamide ID-LV305 0 1
Atezolizumab + CMB305 Atezolizumab CMB305 0 0
CMB305 CMB305 0 2


Additional content available in CKB BOOST